Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Membranous Lupus Nephritis: A Clinical Review.

Almaani S, Parikh SV.

Adv Chronic Kidney Dis. 2019 Sep;26(5):393-403. doi: 10.1053/j.ackd.2019.08.009. Review.

PMID:
31733724
2.

The Kidney Biopsy in Systemic Lupus Erythematosus: A View of the Past and a Vision of the Future.

Ayoub I, Cassol C, Almaani S, Rovin B, Parikh SV.

Adv Chronic Kidney Dis. 2019 Sep;26(5):360-368. doi: 10.1053/j.ackd.2019.08.015. Review.

PMID:
31733720
3.

Lupus Nephritis: How Far Have We Come, and Where Are We Headed?

Lee IJ, Parikh SV.

Adv Chronic Kidney Dis. 2019 Sep;26(5):311-312. doi: 10.1053/j.ackd.2019.09.003. No abstract available.

PMID:
31733714
4.

Collaborating with individuals with lived experience to adapt CANMAT clinical depression guidelines into a patient treatment guide: The CHOICE-D co-design process.

Fonseka TM, Pong JT, Kcomt A, Kennedy SH, Parikh SV.

J Eval Clin Pract. 2019 Nov 14. doi: 10.1111/jep.13308. [Epub ahead of print]

PMID:
31729117
5.

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.

Thase ME, Parikh SV, Rothschild AJ, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Jablonski MR, Greden JF.

J Clin Psychiatry. 2019 Oct 31;80(6). pii: 19m12910. doi: 10.4088/JCP.19m12910.

6.

Masked uncontrolled hypertension.

Mejia-Vilet JM, Bhatt U, Birmingham DJ, Arce C, Hebert CJ, Parikh SV, Nagaraja HN, Hebert LA.

J Hypertens. 2019 Dec;37(12):2501-2502. doi: 10.1097/HJH.0000000000002266. No abstract available.

PMID:
31688297
7.

Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report.

Nogovitsyn N, Muller M, Souza R, Hassel S, Arnott SR, Davis AD, Hall GB, Harris JK, Zamyadi M, Metzak PD, Ismail Z, Downar J, Parikh SV, Soares CN, Addington JM, Milev R, Harkness KL, Frey BN, Lam RW, Strother SC, Rotzinger S, Kennedy SH, MacQueen GM.

Neuropsychopharmacology. 2019 Oct 14. doi: 10.1038/s41386-019-0542-1. [Epub ahead of print]

PMID:
31610545
8.

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.

Ju C, Fiori LM, Belzeaux R, Theroux JF, Chen GG, Aouabed Z, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Uher R, Li Q, Foster JA, Kennedy SH, Turecki G.

Transl Psychiatry. 2019 Oct 8;9(1):254. doi: 10.1038/s41398-019-0589-0.

9.

Rethinking Lupus Nephritis Classification on a Molecular Level.

Almaani S, Prokopec SD, Zhang J, Yu L, Avila-Casado C, Wither J, Scholey JW, Alberton V, Malvar A, Parikh SV, Boutros PC, Rovin BH, Reich HN.

J Clin Med. 2019 Sep 23;8(10). pii: E1524. doi: 10.3390/jcm8101524.

10.

Adapting the Goal Attainment Approach for Major Depressive Disorder.

McCue M, Parikh SV, Mucha L, Sarkey S, Cao C, Eramo A, Opler M, Webber-Lind B, François C.

Neurol Ther. 2019 Dec;8(2):167-176. doi: 10.1007/s40120-019-00151-w. Epub 2019 Aug 21.

11.

Telephone-based cognitive behavioural therapy for female patients 1-year post-bariatric surgery: A pilot study.

Sockalingam S, Leung SE, Hawa R, Wnuk S, Parikh SV, Jackson T, Cassin SE.

Obes Res Clin Pract. 2019 Sep - Oct;13(5):499-504. doi: 10.1016/j.orcp.2019.07.003. Epub 2019 Aug 10.

PMID:
31409544
12.

Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Satoskar AA, Parikh SV, Nadasdy T.

Nat Rev Nephrol. 2019 Aug 9. doi: 10.1038/s41581-019-0178-8. [Epub ahead of print] Review.

PMID:
31399725
13.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators.

N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.

PMID:
31269364
14.

Methodological approaches to situational analysis in global mental health: a scoping review.

Murphy JK, Michalak EE, Colquhoun H, Woo C, Ng CH, Parikh SV, Culpepper L, Dewa CS, Greenshaw AJ, He Y, Kennedy SH, Li XM, Liu T, Soares CN, Wang Z, Xu Y, Chen J, Lam RW.

Glob Ment Health (Camb). 2019 Jun 13;6:e11. doi: 10.1017/gmh.2019.9. eCollection 2019. Review.

15.

Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.

Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Gilbert A, Burns L, Jablonski MR, Dechairo B.

J Psychiatr Res. 2019 Jul;114:211-213. doi: 10.1016/j.jpsychires.2019.04.027. Epub 2019 Apr 27. No abstract available.

PMID:
31101328
16.

Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment.

Belzeaux R, Fiori LM, Lopez JP, Boucekine M, Boyer L, Blier P, Farzan F, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Milev R, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Uher R, Foster JA, Kennedy SH, Turecki G.

J Clin Psychiatry. 2019 May 7;80(3). pii: 18m12556. doi: 10.4088/JCP.18m12556.

PMID:
31087825
17.

An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes.

Thakur VK, Wong JY, Randall JR, Bolton JM, Parikh SV, Mota N, Whitney D, Palay J, Kinley J, Diocee S, Sala T, Sareen J.

BMC Psychiatry. 2019 May 3;19(1):132. doi: 10.1186/s12888-019-2124-5.

18.

Videoconferencing Technology to Facilitate a Pilot Training Course in Advanced Psychopharmacology for Psychiatrists.

Parikh SV, Bostwick JR, Taubman DS.

Acad Psychiatry. 2019 Aug;43(4):411-416. doi: 10.1007/s40596-019-01050-w. Epub 2019 Mar 19.

PMID:
30891683
19.

The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic.

Choi SJ, Storey R, Parikh SV, Bostwick JR.

Psychopharmacol Bull. 2019 Feb 15;49(1):44-55.

PMID:
30858638
20.

Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.

Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Giacobbe P, Hall GB, Harkness KL, Hassel S, Ismail Z, Leri F, McInerney S, MacQueen GM, Minuzzi L, Müller DJ, Parikh SV, Placenza FM, Quilty LC, Ravindran AV, Sassi RB, Soares CN, Strother SC, Turecki G, Vaccarino AL, Vila-Rodriguez F, Yu J, Uher R; CAN-BIND Investigator Team.

J Clin Psychiatry. 2019 Feb 5;80(2). pii: 18m12202. doi: 10.4088/JCP.18m12202.

PMID:
30840787
21.

The Canadian Biomarker Integration Network in Depression (CAN-BIND): magnetic resonance imaging protocols

MacQueen GM, Hassel S, Arnott SR, Jean A, Bowie CR, Bray SL, Davis AD, Downar J, Foster JA, Frey BN, Goldstein BI, Hall GB, Harkness KL, Harris J, Lam RW, Lebel C, Milev R, Müller DJ, Parikh SV, Rizvi S, Rotzinger S, Sharma GB, Soares CN, Turecki G, Vila-Rodriguez F, Yu J, Zamyadi M, Strother SC, Kennedy SH; CAN-BIND Investigator Team.

J Psychiatry Neurosci. 2019 Jul 1;44(4):223-236.

22.

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Macaluso M, Li J, Brown K, Gilbert A, Burns L, Jablonski MR, Dechairo B.

J Psychiatr Res. 2019 Apr;111:59-67. doi: 10.1016/j.jpsychires.2019.01.003. Epub 2019 Jan 4.

23.

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project.

Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, Duffy A, Alda M, Calkin C, Sharma V, Anand A, Singh MK, Hajek T, Boyce P, Frey BN, Castle DJ, Young AH, Vieta E, Rybakowski JK, Swartz HA, Schaffer A, Murray G, Bayes A, Lam RW, Bora E, Post RM, Ostacher MJ, Lafer B, Cleare AJ, Burdick KE, O'Donovan C, Ortiz A, Henry C, Kanba S, Rosenblat JD, Parikh SV, Bond DJ, Grunebaum MF, Frangou S, Goldberg JF, Orum M, Osser DN, Frye MA, McIntyre RS, Fagiolini A, Manicavasagar V, Carlson GA, Malhi GS.

Aust N Z J Psychiatry. 2018 Oct 31:4867418808382. doi: 10.1177/0004867418808382. [Epub ahead of print]

PMID:
30378461
24.

Toward Effective Work Accommodations for Depression: Examining the Relationship Between Different Combinations of Depression Symptoms and Work Productivity Losses.

Dewa CS, Hoch JS, Nieuwenhuijsen K, Parikh SV, Sluiter JK.

J Occup Environ Med. 2019 Jan;61(1):75-80. doi: 10.1097/JOM.0000000000001486.

PMID:
30358657
25.

Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Mejia-Vilet JM, Parikh SV, Song H, Fadda P, Shapiro JP, Ayoub I, Yu L, Zhang J, Uribe-Uribe N, Rovin BH.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1197-1206. doi: 10.1093/ndt/gfy125.

PMID:
29800348
26.

The Michigan Bright Nights Community Forum Series: a 10-Year Experience with Public Mental Health Education.

Taubman DS, Salazar L, Salazar S, Meyer T, Grimes TP, Parikh SV.

Acad Psychiatry. 2019 Apr;43(2):235-238. doi: 10.1007/s40596-018-0912-8. Epub 2018 Apr 11. No abstract available.

PMID:
29644601
27.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M.

Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.

28.

The Michigan Peer-to-Peer Depression Awareness Program: School-Based Prevention to Address Depression Among Teens.

Parikh SV, Taubman DS, Antoun C, Cranford J, Foster CE, Grambeau M, Hunter J, Jester J, Konz K, Meyer T, Salazar S, Greden JF.

Psychiatr Serv. 2018 Apr 1;69(4):487-491. doi: 10.1176/appi.ps.201700101. Epub 2018 Mar 1.

PMID:
29493416
29.

More data, more answers: picking the optimal antidepressant.

Parikh SV, Kennedy SH.

Lancet. 2018 Apr 7;391(10128):1333-1334. doi: 10.1016/S0140-6736(18)30421-5. Epub 2018 Feb 21. No abstract available.

30.

The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.

Baskaran A, Farzan F, Milev R, Brenner CA, Alturi S, Pat McAndrews M, Blier P, Evans K, Foster JA, Frey BN, Giacobbe P, Lam RW, Leri F, MacQueen GM, Müller DJ, Parikh SV, Rotzinger S, Soares CN, Strother SC, Turecki G, Kennedy SH; CAN-BIND Investigators Team.

J Affect Disord. 2018 Feb;227:542-549. doi: 10.1016/j.jad.2017.10.028. Epub 2017 Nov 3.

PMID:
29169123
31.

Quality of life in bipolar disorder: towards a dynamic understanding.

Morton E, Murray G, Michalak EE, Lam RW, Beaulieu S, Sharma V, Cervantes P, Parikh SV, Yatham LN.

Psychol Med. 2018 May;48(7):1111-1118. doi: 10.1017/S0033291717002495. Epub 2017 Sep 18.

PMID:
28918761
32.
33.

MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.

Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, Farzan F, Leri F, MacQueen GM, Feilotter H, Tyryshkin K, Evans KR, Giacobbe P, Blier P, Lam RW, Milev R, Parikh SV, Rotzinger S, Strother SC, Lewis CM, Aitchison KJ, Wittenberg GM, Mechawar N, Nestler EJ, Uher R, Kennedy SH, Turecki G.

Nat Commun. 2017 May 22;8:15497. doi: 10.1038/ncomms15497.

34.

Response to Letter Regarding CANMAT Recommendations for the Pharmacological Treatment of Late-life Depression.

Lam RW, Ismail Z, MacQueen GM, Milev RV, Parikh SV, Ravindran AV, Kennedy SH.

Can J Psychiatry. 2017 May;62(5):353-354. doi: 10.1177/0706743717700878. No abstract available.

35.

Bipolar disorder research 2.0: Web technologies for research capacity and knowledge translation.

Michalak EE, McBride S, Barnes SJ, Wood CS, Khatri N, Balram Elliott N, Parikh SV; And the Collaborative RESearch Team to study psychosocial in Bipolar Disorder (CREST.BD).

J Eval Clin Pract. 2017 Dec;23(6):1144-1152. doi: 10.1111/jep.12736. Epub 2017 May 4.

36.

Rating Short-Term Psychodynamic Therapy for the Canadian Network for Mood and Anxiety Treatments Depression Guidelines.

Parikh SV, Quilty L, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Uher R, Kennedy SH, Lam RW, MacQueen GM, Milev R, Ravindran AV.

Can J Psychiatry. 2017 Jan;62(1):77-78. doi: 10.1177/0706743716676754. No abstract available.

37.

The effect of remission status on work functioning in employed patients treated for major depressive disorder.

Sarfati D, Stewart K, Woo C, Parikh SV, Yatham LN, Lam RW.

Ann Clin Psychiatry. 2017 Feb;29(1):11-16.

PMID:
27901522
38.

Molecular imaging of the kidney in lupus nephritis to characterize response to treatment.

Parikh SV, Malvar A, Song H, Alberton V, Lococo B, Vance J, Zhang J, Yu L, Birmingham D, Rovin BH.

Transl Res. 2017 Apr;182:1-13. doi: 10.1016/j.trsl.2016.10.010. Epub 2016 Nov 1.

39.

A Pilot Study on Telephone Cognitive Behavioral Therapy for Patients Six-Months Post-Bariatric Surgery.

Sockalingam S, Cassin SE, Wnuk S, Du C, Jackson T, Hawa R, Parikh SV.

Obes Surg. 2017 Mar;27(3):670-675. doi: 10.1007/s11695-016-2322-x.

40.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, Modirrousta M, Patry S, Vila-Rodriguez F, Lam RW, MacQueen GM, Parikh SV, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):561-75. doi: 10.1177/0706743716660033. Epub 2016 Aug 2. Review.

41.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 5. Complementary and Alternative Medicine Treatments.

Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, Ravindran L, Yatham LN, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Parikh SV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):576-87. doi: 10.1177/0706743716660290. Epub 2016 Aug 2. Review.

42.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Introduction and Methods.

Lam RW, Kennedy SH, Parikh SV, MacQueen GM, Milev RV, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):506-9. doi: 10.1177/0706743716659061. Epub 2016 Aug 2. No abstract available.

43.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.

Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, Sareen J, Song WY, Kennedy SH, MacQueen GM, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):510-23. doi: 10.1177/0706743716659416. Epub 2016 Aug 2. Review.

44.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, Velyvis V, Kennedy SH, Lam RW, MacQueen GM, Milev RV, Ravindran AV, Uher R; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):524-39. doi: 10.1177/0706743716659418. Epub 2016 Aug 2. Review.

45.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly.

MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, Kennedy SH, Lam RW, Milev RV, Parikh SV, Ravindran AV; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):588-603. doi: 10.1177/0706743716659276. Epub 2016 Aug 2. Review. Erratum in: Can J Psychiatry. 2017 May;62(5):356.

46.

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, Hasnain M, Jollant F, Levitt AJ, MacQueen GM, McInerney SJ, McIntosh D, Milev RV, Müller DJ, Parikh SV, Pearson NL, Ravindran AV, Uher R; CANMAT Depression Work Group.

Can J Psychiatry. 2016 Sep;61(9):540-60. doi: 10.1177/0706743716659417. Epub 2016 Aug 2. Review. Erratum in: Can J Psychiatry. 2017 May;62(5):356.

47.

Current and Emerging Therapies for Lupus Nephritis.

Parikh SV, Rovin BH.

J Am Soc Nephrol. 2016 Oct;27(10):2929-2939. Epub 2016 Jun 9. Review.

48.

Improving continuing medical education by enhancing interactivity: lessons from Iran.

Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Parikh SV, Shirazi M.

J Adv Med Educ Prof. 2016 Apr;4(2):54-63.

49.

Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.

Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR, Farzan F, Foster JA, Frey BN, Geraci J, Giacobbe P, Feilotter HE, Hall GB, Harkness KL, Hassel S, Ismail Z, Leri F, Liotti M, MacQueen GM, McAndrews MP, Minuzzi L, Müller DJ, Parikh SV, Placenza FM, Quilty LC, Ravindran AV, Salomons TV, Soares CN, Strother SC, Turecki G, Vaccarino AL, Vila-Rodriguez F, Kennedy SH; CAN-BIND Investigator Team.

BMC Psychiatry. 2016 Apr 16;16:105. doi: 10.1186/s12888-016-0785-x.

50.

A pilot randomized controlled trial of telephone-based cognitive behavioural therapy for preoperative bariatric surgery patients.

Cassin SE, Sockalingam S, Du C, Wnuk S, Hawa R, Parikh SV.

Behav Res Ther. 2016 May;80:17-22. doi: 10.1016/j.brat.2016.03.001. Epub 2016 Mar 10.

Supplemental Content

Loading ...
Support Center